Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX
Frank Steven received 1,288 Biocryst Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Frank Steven (Director) received 1,288 Biocryst Pharmaceuticals, Inc. shares as an award at US$9.70 for US$12,494, leaving 36,747 shares. Filed Sep 2, 2026 (Form 4).
- Awarded
- 1,288 shares
- Price
- US$9.70
- Value
- US$12,494
- Holding after
- 36,747 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Award | 1,288 | US$9.70 | 36,747 | Direct |
Source
Related
- Biocryst Pharmaceuticals, Inc.
- Frank Steven
- Biocryst Pharmaceuticals, Inc. shareholders
- Form 4 · Frank Steven · Jun 15, 2026
- Form 4 · Frank Steven · Jun 2, 2026
- Form 4 · Stonehouse Jon P · Sep 2, 2026
- Form 4 · Milne Jill C. · Sep 2, 2026
- Form 4 · Milano Vincent · Sep 2, 2026
- Form 4 · McKee Amy E · Sep 2, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026